Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Relling

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Clinical Pharmacology and Therapeutics|May 30, 2008
Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemiaJ Yang, A Bogni, C Cheng, et al.
The New England Journal of Medicine|June 19, 1997
Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemiaC H Pui, J M Boyett, W T Hughes, et al.
Leukemia|June 22, 2001
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphomaR C Ribeiro, B D Fletcher, W Kennedy, et al.
Pediatric Blood & Cancer|January 8, 2014
Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL)S C Kaste, A Qi, K Smith, et al.
Clinical Pharmacology and Therapeutics|February 21, 2013
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 updateM V Relling, E E Gardner, W J Sandborn, et al.
Leukemia|February 12, 1999
Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroupJ E Rubnitz, F G Behm, D Wichlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemiaM H Woo, L J Hak, M C Storm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemiaC H Pui, J E Rubnitz, M L Hancock, et al.
Clinical Pharmacology and Therapeutics|August 11, 2017
New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision MedicineM V Relling, R M Krauss, D M Roden, et al.
Blood|July 10, 1998
Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemiaC H Pui, H H Mahmoud, G K Rivera, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Clinical Pharmacology and Therapeutics|May 30, 2008
Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemiaJ Yang, A Bogni, C Cheng, et al.
The New England Journal of Medicine|June 19, 1997
Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemiaC H Pui, J M Boyett, W T Hughes, et al.
Leukemia|June 22, 2001
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphomaR C Ribeiro, B D Fletcher, W Kennedy, et al.
Pediatric Blood & Cancer|January 8, 2014
Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL)S C Kaste, A Qi, K Smith, et al.
Clinical Pharmacology and Therapeutics|February 21, 2013
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 updateM V Relling, E E Gardner, W J Sandborn, et al.
Leukemia|February 12, 1999
Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroupJ E Rubnitz, F G Behm, D Wichlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemiaM H Woo, L J Hak, M C Storm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemiaC H Pui, J E Rubnitz, M L Hancock, et al.
Clinical Pharmacology and Therapeutics|August 11, 2017
New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision MedicineM V Relling, R M Krauss, D M Roden, et al.
Blood|July 10, 1998
Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemiaC H Pui, H H Mahmoud, G K Rivera, et al.
Pageof 18